The U.S. Food and Drug Administration (FDA) doesn’t just review drug labels or approve new treatments - it sends inspectors into factories, labs, and production lines to make sure what gets made is safe, consistent, and meets the law. These FDA facility inspections are the backbone of quality control for everything from heart medications to insulin pumps, baby formula to surgical tools. If you’ve ever taken a prescription, used an inhaler, or even eaten a packaged meal, chances are the facility that made it was inspected by the FDA. And if it wasn’t done right, the product never reaches you.
Why Inspections Matter More Than You Think
Inspections aren’t about catching mistakes after they happen. They’re about stopping problems before they start. Think of them like a yearly health checkup - but for a manufacturing plant. One poorly trained employee, a broken machine, or a missing document can lead to contaminated medicine, faulty devices, or even deadly outcomes. The FDA doesn’t wait for reports of harm. They show up unannounced, review records, talk to staff, and walk the floors to see how things really work.
In 2022, the FDA inspected over 13,000 facilities worldwide - 12,000 in the U.S. and 1,000 overseas. That’s not luck. It’s strategy. The agency uses a risk-based system to decide who gets visited first. A facility making life-saving cancer drugs? Likely inspected every 6 to 12 months. A factory making low-risk dietary supplements? Maybe once every 4 years. The decision comes down to three things: how serious the product is, how often the facility has messed up before, and whether they’re using new or untested manufacturing methods.
The Four Types of FDA Inspections
Not all inspections are the same. The FDA has four distinct types, each with its own purpose and timing.
- Pre-approval inspections happen before a new drug or device gets approved. If a company submits a PMA (Pre-Market Approval), the FDA will send inspectors to the facility within 30 days of saying it’s ready. This isn’t a formality - it’s a make-or-break moment. If they find major issues with how the product is made, the approval gets delayed or denied.
- Routine surveillance inspections are the most common. They’re scheduled every 2 to 5 years based on risk. These are comprehensive checks of everything: equipment, records, staff training, and quality systems. The goal? To confirm ongoing compliance with Current Good Manufacturing Practices (CGMP).
- Compliance follow-up inspections happen after a facility got a Form 483 (more on that later). The FDA comes back to see if the problems were fixed. Missing this step means you’re still in violation - and you could be shut down.
- For-cause inspections are the surprise visits. Triggered by complaints, whistleblower tips, sudden spikes in adverse events, or reports of contamination. These can happen with zero notice. No warning. No prep time. Just an inspector showing up with credentials and a Form 482.
What Happens During an Inspection?
When the inspector walks in, they hand you FDA Form 482 - the official notice of inspection. You can’t refuse entry. You can’t delay. You must assign a representative to accompany them the entire time. This isn’t optional. It’s the law.
The inspection lasts anywhere from 3 to 10 days. Here’s what they look at:
- Facility tour: They walk through every room - clean rooms, storage areas, packaging lines. They check for pest infestations, unclean surfaces, poor labeling, or equipment that hasn’t been maintained.
- Records review: This is where most failures happen. They pull everything: deviation logs, training records, validation reports, equipment calibration data, batch production records. If a document is missing, outdated, or incomplete, it becomes an observation.
- Staff interviews: They ask questions. Simple ones. Like, “What do you do if a machine breaks during production?” or “How do you know this batch is safe?” If answers don’t match the written procedures, red flags go up.
- Sample collection: They might take samples of raw materials, finished products, or even swabs from surfaces. These get sent to labs for testing.
At the end, the inspector gives you FDA Form 483 - a written list of objectionable conditions. It’s not a fine. It’s a warning. But if you ignore it, the next step is a warning letter, a product recall, or even a court order to stop production.
The Biggest Reasons Facilities Fail
Industry data from 2023 and 2024 shows the same problems over and over. Seven out of ten observations come from just four areas:
- Inadequate deviation investigations (32%): When something goes wrong - a batch fails, a machine overheats - you must investigate why. Not just fix it. Not just log it. You must find the root cause. Many companies skip this step. That’s a huge red flag.
- Incomplete training records (24%): Every person who touches the product must be trained. And you must prove it. If your training logs are missing, outdated, or show someone was trained on a process they’ve never done, inspectors will flag it.
- Insufficient validation documentation (15%): You can’t just say “this process works.” You have to prove it. Validation data for equipment, cleaning methods, and production steps must be thorough, current, and signed off.
- Poor change control records (7%): If you change a machine, a supplier, or a procedure, you must document it, test it, and get approval. Skipping change control is like driving without a license.
And here’s the growing problem: data integrity. In 2020, data issues made up 28% of observations. By 2023, that jumped to 45%. Why? Because more systems are digital. Inspectors now check electronic records, audit trails, user access logs, and system validation. If your computer system allows someone to delete a record without a trace - you’re in trouble.
How to Get Ready - And Stay Ready
Most facilities panic when they hear an inspection is coming. But the best ones don’t wait. They build inspection readiness into their daily operations.
Here’s what works:
- Do quarterly mock inspections: Bring in someone from outside to simulate the real thing. Use the same Form 483 checklist. Find your own problems before the FDA does.
- Designate one inspection coordinator: Facilities that use a single point of contact complete inspections 22% faster. No confusion. No conflicting answers.
- Keep your facility diagram updated: One Reddit user said it best: “Inspectors notice if the layout changed and you didn’t update the diagram.” A single mismatch can make them doubt everything.
- Set up a dedicated inspection room: Have printers, computers, phones, and organized document folders ready. Facilities that did this resolved document requests 40% faster.
- Train staff annually: Everyone who talks to inspectors - even janitors - needs 8 hours of training. Principal investigators need 16. Only 63% of sites meet this. Don’t be one of them.
And don’t forget the basics: clean floors, labeled storage, organized shelves. Inspectors notice clutter. It makes them wonder what else is messy.
What’s Changing in 2025 and Beyond
The FDA isn’t standing still. By 2026, they plan to use remote tools for 35% of inspections. Virtual tours and remote document reviews are already being tested. In 2023, 147 facilities went through this pilot. Results? For 78% of documentation checks, it was just as effective as being there.
By Q3 2025, the FDA will start using AI to review documents. It won’t replace inspectors - it’ll help them find patterns faster. If a facility has 10,000 records, AI can spot missing signatures, duplicate entries, or inconsistent dates in seconds.
Inspection frequency is shifting too. High-risk products - especially those for older adults - will see more visits. Low-risk dietary supplements? Fewer. The FDA is getting smarter about where to spend its resources.
And remember: records must be kept for at least 2 years after a product is discontinued. In 2023, 87% of Form 483 issues were about missing or expired records. If you think you can toss old files after a year - you’re risking your whole operation.
Final Thought: It’s Not About Passing - It’s About Protecting
FDA inspections aren’t a hurdle. They’re a safeguard. Every time a facility passes an inspection, it means someone’s life is protected. A child with a rare disease gets their medicine. An elderly patient gets a safe implant. A hospital gets reliable equipment.
Don’t treat inspections like a threat. Treat them like feedback. Build systems that don’t just survive inspection - they thrive because of it. Because when you do, you’re not just following rules. You’re making sure what’s made in your facility is worthy of being used by someone who trusts you with their health.
What happens if a facility refuses an FDA inspection?
Refusing an FDA inspection is illegal under 21 CFR 10.20. The agency can obtain a court order to force entry. Facilities that refuse are automatically flagged as non-compliant. This leads to product seizures, import bans, and potential criminal charges. No facility that denies entry can legally sell its products in the U.S.
How long does an FDA inspection typically last?
Most inspections last between 3 and 10 days. Simple facilities with clean records may finish in 3-4 days. Complex sites - like those making biologics or combination devices - can take a week or longer. The length depends on the number of products, the complexity of processes, and how well records are organized.
Can a facility appeal a Form 483 observation?
You can’t appeal the Form 483 itself - it’s a factual report of what the inspector observed. But you can respond in writing within 15 working days with your corrective action plan. This response becomes part of the official record. If your plan is thorough and credible, the FDA may close the observation without further action. A weak response can lead to a warning letter.
What’s the difference between a Form 483 and a warning letter?
Form 483 is a list of observations - problems the inspector noticed. A warning letter is a formal notice of violation. It’s issued if the FDA believes the issues are serious enough to threaten public health. Warning letters are public, can trigger product recalls, and may lead to import bans or legal action. Form 483 is a heads-up. A warning letter is a red alert.
Do FDA inspectors check for environmental controls?
Yes. For facilities making sterile products - like injectables or implants - inspectors check air quality, pressure differentials, filtration systems, and personnel gowning procedures. They look at environmental monitoring data, including particle counts and microbial results. If a cleanroom fails to maintain required standards, the entire production line can be halted.
How often are foreign facilities inspected?
The FDA inspects about 1,000 foreign facilities each year. But not all get visited in person. Due to travel restrictions and risk profiles, some are assessed remotely or through third-party audits. However, high-risk foreign sites - especially those supplying critical drugs - are prioritized for in-person inspections. The FDA has increased foreign inspection capacity since 2020, with a goal of inspecting 60% of high-risk foreign facilities every 3 years.
What happens if a facility gets a warning letter?
A warning letter triggers a mandatory response within 15 days. The facility must submit a detailed corrective action plan. If the FDA finds the plan inadequate, they may refuse to approve new products, block imports, or initiate legal proceedings. Companies that ignore warning letters risk being placed on the FDA’s Import Alert list - meaning all future shipments are automatically detained at the border.
Can a facility be inspected more than once in a year?
Yes. High-risk facilities - those with recent violations, recalls, or complaints - can be inspected multiple times in a year. The FDA doesn’t follow a rigid calendar. If new evidence emerges, they’ll return. A routine inspection in January doesn’t mean you’re safe for the rest of the year.
